The STOPAH trial included 1103 patients with SAH who were randomized to placebo, prednisolone, pentoxifylline, or both prednisolone and pentoxifylline, and showed a trend towards improving 28-day mortality in the steroid arm that did not reach significance[ 18 ].
← all excerpts
Predictors and prognosticators of outcomes in alcoholic hepatitis: A retrospective single center study.
1
—
—